|
Overcoming Prostate Cancer Resistance through Inhibition of Translesion DNA Synthesis & Repurposing beta-blockers to license immunotherapy in brain tumors |
07/19/2023 - 8:00am to 9:00am EDT |
|
National Chemotherapy Shortages and the Impact on Oncologic Care in North Carolina / Thoughts for a New Academic Year: Burnout, Grief, & Education |
07/26/2023 - 8:00am to 9:00am EDT |
|
Investigating the non-canonical role of Hippo Kinase, serine/threonine kinase 3 (STK3) in prostate cancer / Investigating the Impact of ABL Kinase Signaling on Epigenetic Reprogramming in Metastatic Triple Negative Breast Cancer |
08/02/2023 - 8:00am to 9:00am EDT |
|
The role of estrogens in modulating natural killer cells in breast cancer metastasis / A Research Update on Treatment Complications of Venous Thromboembolism in Patients with Central Nervous System Tumors |
08/09/2023 - 8:00am to 9:00am EDT |
|
Enhancing natural killer cell cytotoxicity by targeting HLA-E / AIMing for a Novel B Cell Checkpoint in cGVHD and Lymphoma |
08/16/2023 - 8:00am to 9:00am EDT |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2023 |
08/23/2023 - 8:00am to 9:00am EDT |
|
Targeting HER2 in Metastatic Colorectal Cancer: The Current Landscape and Mechanisms of Resistance & Fertility Preservation and Pregnancy in Young Women with Breast Cancer |
08/30/2023 - 8:00am to 9:00am EDT |
|
Hematology Division Updates |
09/06/2023 - 8:00am to 9:00am EDT |
|
Division of Hematologic Malignancies & Cellular Therapy Updates Part 1 |
09/13/2023 - 8:00am to 9:00am EDT |
|
Division of Hematologic Malignancies & Cellular Therapy Updates Part 2 |
09/20/2023 - 8:00am to 9:00am EDT |
Facebook
Twitter
LinkedIn
Forward